Table 3 Difference in parameters with PFS > 4 months versus PFS ≤ 4 months
Modality | Parameters | PFS ≤ 4 months | PFS > 4 months | p value |
|---|---|---|---|---|
CT | Sum of uni-dimensional measurements of target lesions (cm) | 74.6 ± 42.8 | 69.2 ± 23.2 | 0.87 |
FDG | Highest SUVmax | 12.8 ± 5.6 | 11.7 ± 4.4 | 0.95 |
Sum of SUVmax | 38.8 ± 41.6 | 28.6 ± 21.4 | 0.90 | |
MTV | 138.0 ± 129.0 | 57.6 ± 43.5 | 0.19 | |
TLG | 707.9 ± 701.7 | 292.3 ± 240.7 | 0.21 | |
SUL | 10.0 ± 4.8 | 7.6 ± 3.3 | 0.28 | |
%Δhighest SUVmax | − 12.2 ± 37.8 | − 12.0 ± 80.7 | 0.42 | |
%Δsum of SUVmax | − 19.2 ± 39.8 | − 6.4 ± 85.1 | 0.79 | |
%ΔMTV | − 10.4 ± 59.4 | − 29.1 ± 45.8 | 0.42 | |
%ΔTLG | − 10.9 ± 99.7 | − 32.4 ± 79.0 | 0.33 | |
%ΔSUL | − 26.8 ± 47.5 | − 34.4 ± 66.1 | 0.39 | |
4DST | Highest SUVmax | 6.8 ± 2.4 | 5.7 ± 1.7 | 0.11 |
Sum of SUVmax | 19.4 ± 17.8 | 22.8 ± 21.0 | 0.84 | |
MTV | 127.7 ± 127.8 | 50.3 ± 29.2 | 0.06 | |
TLP | 384.4 ± 371.0 | 158.4 ± 116.0 | 0.09 | |
%Δhighest SUVmax | 11.9 ± 37.3 | − 5.6 ± 47.9 | 0.33 | |
%Δsum of SUVmax | 9.1 ± 49.5 | − 18.6 ± 56.9 | 0.19 | |
%ΔMTV | − 18.9 ± 45.7 | − 36.9 ± 52.4 | 0.33 | |
%ΔTLP | − 5.2 ± 77.9 | − 32.9 ± 60.3 | 0.37 |